Thermally reversible xyloglucan gels as vehicles for nasal drug delivery

Drug Delivery

Volumn 19, Issue 5, 2012, Pages 270-276

  Mahajan, Hitendra S ^a   Tyagi, Vinod ^a   Lohiya, Gopal ^a   Nerkar, Pankaj ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Drug delivery; in situ gel; Nasal; Xyloglucan

Indexed keywords

BETA GALACTOSIDASE; GALACTOSE; ONDANSETRON; POLYMER; POLYSACCHARIDE; UNCLASSIFIED DRUG; XYLOGLUCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION (PARAMETERS); DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; ENZYME DEGRADATION; EX VIVO STUDY; EXPERIMENTAL RABBIT; FLOW KINETICS; GEL; GELATION; HEAT SENSITIVITY; HISTOLOGY; IN VITRO STUDY; LOW TEMPERATURE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; NOSE MUCOSA; PLANT SEED; PRIORITY JOURNAL; TAMARIND; TIME TO MAXIMUM PLASMA CONCENTRATION; VISCOSITY;

ABSORPTION; ANIMALS; BETA-GALACTOSIDASE; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; GALACTOSE; GELS; GLUCANS; KINETICS; NASAL MUCOSA; ONDANSETRON; PHARMACEUTICAL VEHICLES; POLYSACCHARIDES; RABBITS; SEEDS; TAMARINDUS; TEMPERATURE; XYLANS;

EID: 84864236902     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2012.704095     Document Type: Article

References (25)

1. Belgamwar VS, Chauk DS, Mahajan HS, Jain SA, Gattani SG, Surana SJ. Formulation and evaluation of in situ gelling system of dimenhydrinate for nasal administration. Pharm Dev Technol 2009;14:240-248.
2. Brandl F, Sommer F, Goepferich A. Rational design of hydrogels for tissue engineering: impact of physical factors on cell behavior. Biomaterials;28:134- 146.
3. Cerchiara T, Luppi B, Chidichimo G, Bigucci F, Zecchi V. Chitosan and poly(methyl vinyl ether-co-maleic anhydride) microparticles as nasal sustained delivery systems. Eur J Pharm Biopharm 2005;61:195-200. (Pubitemid 41427627)
4. Eunsook C, Hyesun G, Inkoo C. Formulation and evaluation of ondansetron nasal delivery systems. Int J Pharm 2008;349:101-107.
5. Gil ES, Hudson SM. Stimuli-responsive polymers and their bioconjugates. Prog Polym Sci 2004;29:1173-1222.
6. Kawasaki N, Ohkura R, Miyazaki S, Uno Y, Sugimoto S, Attwood D. Thermally reversible xyloglucan gels as vehicles for oral drug delivery. Int J Pharm 1999;181:227-234. (Pubitemid 29229809)
7. Mahajan HS, Gattani SG. In situ gels of Metoclopramide Hydrochloride for intranasal delivery: In vitro evaluation and in vivo pharmacokinetic study in rabbits. Drug Deliv 2010;17:19-27.
8. Mahajan HS, Gattani SG. Nasal administration of ondansetron using a novel microspheres delivery system Part II: ex vivo and in vivo studies. Pharm Dev Technol 2010;15:653-657.
9. Mahajan HS, Shah SK, Surana SJ. Nasal in situ gel containing hydroxy propyl β-cyclodextrin inclusion complex of artemether: development and in vitro evaluation. J Incl Phenom Macrocycl Chem 2011;70:49-58.
10. Masteikov R, Chalupov Z, Sklubalov Z. Stimuli-sensitive hydrogels in controlled and sustained drug delivery. Medicina (Kaunas) 2003;39 Suppl 2:19-24.
11. Mitchka P. Simple conversion of Brookfield R.V.T readings into viscosity functions. Rheol Acta 1982;21:207-209.
12. Miyazaki S, Suisha F, Kawasaki N, Shirakawa M, Yamatoya K, Attwood D. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery. J Control Release 1998;56:75-83. (Pubitemid 28511128)
13. Miyazaki S, Kawasaki N, Endo K, Attwood D. Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits. J Pharm Pharmacol 2001;53:1185-1191. (Pubitemid 32904012)
14. Owen DH, Peters JJ, Katz DF. Rheological properties of contraceptive gels. Contraception 2006;2:321-326.
15. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60:110-111.
16. Reid JSG, Edwards M. Dea ICM, Phillips GO, Wedlock DJ, Williams PA, eds. Gums and Stabilizers for the Food Industry. Oxford: IRL Press, 1988:391.
17. Reiter WD. Biosynthesis and properties of the plant cell wall. Curr Opin Plant Biol 2002;5:536-542.
18. Rita JM, Pradip KG, Manish LU, Rayasa SR. Thermoreversible mucoadhesive gel for nasal delivery of sumatriptan. AAPS Pharm Sci Tech 2006;7:E1-E7.
19. Schmaljohann D. Thermo-and pH-responsive polymers in drug delivery. Adv Drug Deliv Rev 2006;58:1655-1670. (Pubitemid 44830149)
20. Shirakawa M, Yamotoya K, Nishinari K. Tailoring of xyloglucan properties using an enzyme. Food Hydrocolloid 1998;12:25-28.
21. Suisha F, Kawasaki N, Miyazaki S, Shirakawa M, Yamatoya K, Sasaki M, Attwood D. Xyloglucan gels as sustained release vehicles for the intraperitoneal administration of mitomycin C. Int J Pharm 1998;172:27-32. (Pubitemid 28430242)
22. Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 2001;53:3-21. (Pubitemid 32140298)
23. Yamatoya K, Shirakawa M, Kuwano K, Suzuki J, Baba O. Hypolipidemic effects of hydrolyzed xyloglucan. Macromol Symp 1997;120:231-236.
24. Yuguchi Y, Mimura M, Urakawa H, Kajiwara K, Shirakawa M, Yamatoya K, Kitamura S. Cross-linking structure formation of some polysaccharides in aqueous solution. In: Adisesha HT, Sudirjo ST, Panggabean PR, Arda J, Soetrono CW, eds. Proceedings of the International Workshop on Green Polymers-Re-evaluation of Natural Polymers. Indonesia: Indonesian Polymer Association 1997:306-329.
25. Yu L, Chang GT, Zhang H, Ding JD. Injectable block copolymer hydrogels for sustained release of a PEGylated drug. Int J Pharm 2008;348:95-106. (Pubitemid 350278554)